|
Michael J. Choate, Esq.
Proskauer Rose LLP 70 West Madison, Suite 3800 Chicago, Illinois 60602-4342 Tel: (312) 962-3567 |
| |
Daniel L. Forman, Esq.
Proskauer Rose LLP Eleven Times Square New York, NY 10036 (212) 969-3000 |
| |
James A. Tanaka, Esq.
Chief Securities Counsel & EVP AR Global 405 Park Avenue, 3rd Floor New York, NY 10022 Tel: (212) 415-6500 |
| |
Dean M. Colucci, Esq.
Kelly A. Dabek, Esq. Duane Morris LLP 1540 Broadway New York, NY (212) 692-1000 |
|
| Large accelerated filer ☐ | | | Accelerated filer ☐ | | | Non-accelerated filer ☒ | | | Smaller reporting company ☐ | |
| | | | | | | | | | Emerging growth company ☐ | |
|
CALCULATION OF REGISTRATION FEE
|
| ||||||||||||||
|
Title of Securities Being Registered
|
| | |
Proposed Maximum
Aggregate Offering Price(1) |
| | |
Amount of
Registration Fee |
| ||||||
|
Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share
|
| | | | $ | 40,250,000 | | | | | | $ | 5,224.45 | | |
| | |
Per Share
|
| |
Total
|
| ||||||
Public offering price
|
| | | $ | | | | | $ | | | | |
Underwriting discount(1)
|
| | | $ | | | | | | $ | | | |
Proceeds, before expenses, to us
|
| | | $ | | | | | | $ | | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 5 | | | |
| | | | 12 | | | |
| | | | 54 | | | |
| | | | 56 | | | |
| | | | 57 | | | |
| | | | 70 | | | |
| | | | 72 | | | |
| | | | 95 | | | |
| | | | 99 | | | |
| | | | 99 | | | |
| | | | 99 | | |
| | |
Number of Shares Beneficially Owned
|
| | | | | | | |||||||||
Beneficial Owner(1)
|
| |
Common Stock
|
| |
Series A
Preferred Stock |
| |
Percent of
Common Stock |
| |||||||||
Edward M. Weil, Jr.(2)
|
| | | | — | | | | | | — | | | | | | — | | |
Katie P. Kurtz
|
| | | | — | | | | | | — | | | | | | — | | |
Leslie D. Michelson(3)
|
| | | | 302,680 | | | | | | — | | | | | | * | | |
Lee M. Elman(4)
|
| | | | 26,347 | | | | | | — | | | | | | * | | |
B.J. Penn(5)
|
| | | | 15,000 | | | | | | — | | | | | | * | | |
Edward G. Rendell(6)
|
| | | | 27,680 | | | | | | — | | | | | | * | | |
Elizabeth K. Tuppeny(7)
|
| | | | 30,346 | | | | | | — | | | | | | * | | |
All directors and executive officers as a group (seven persons)
|
| | | | 402,053 | | | | | | — | | | | | | * | | |
Underwriter
|
| |
Number of Shares
|
| |||
B. Riley FBR, Inc.
|
| | | | | | |
Total
|
| | | | | |
| | |
No Exercise
|
| |
Full Exercise
|
| ||||||
Per share
|
| | | $ | | | | | $ | | | ||
Total
|
| | | $ | | | | | $ | | |
|
Securities and Exchange Commission Registration Fee
|
| | | $ | 5,225 | | |
|
FINRA Filing Fee
|
| | | $ | 6,538 | | |
|
Nasdaq Filing Fee
|
| | | $ | * | | |
|
Legal Fees and Expenses
|
| | | $ | * | | |
|
Accounting Fees and Expenses
|
| | | $ | * | | |
|
Printing Fees and Expenses
|
| | | $ | * | | |
|
Transfer Agent Fees and Expenses
|
| | | $ | * | | |
|
Miscellaneous Expenses
|
| | | $ | * | | |
|
Total
|
| | | $ | * | | |
Exhibit No.
|
| |
Description
|
|
23.2** | | | Consent of Venable LLP (included in Exhibit 5.1) | |
23.3** | | | Consent of Proskauer Rose LLP (included in Exhibit 8.1) | |
24.1* | | | Power of Attorney (included on the signature page to this Registration Statement) | |
| | | | HEALTHCARE TRUST, INC. | | |||
| | | | By: | | |
/s/ Edward M. Weil, Jr.
Edward M. Weil, Jr.
Chief Executive Officer and President (Principal Executive Officer) |
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Edward M. Weil, Jr.
Edward M. Weil, Jr.
|
| | Chief Executive Officer, President and Director (Principal Executive Officer) | | |
November 4, 2019
|
|
|
/s/ Lee M. Elman
Lee M. Elman
|
| | Independent Director | | |
November 4, 2019
|
|
|
/s/ Leslie D. Michelson
Leslie D. Michelson
|
| | Independent Director | | |
November 4, 2019
|
|
|
/s/ B.J. Penn
B.J. Penn
|
| | Independent Director | | |
November 4, 2019
|
|
|
/s/ Edward G. Rendell
Edward G. Rendell
|
| | Independent Director | | |
November 4, 2019
|
|
|
/s/ Elizabeth K. Tuppeny
Elizabeth K. Tuppeny
|
| | Independent Director | | |
November 4, 2019
|
|
|
/s/ Katie P. Kurtz
Katie P. Kurtz
|
| | Chief Financial Officer, Secretary and Treasurer (Principal Financial Officer and Principal Accounting Officer) | | |
November 4, 2019
|
|
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Healthcare Trust, Inc.:
We consent to the use of our report dated March 13, 2019, with respect to the consolidated balance sheets of Healthcare Trust, Inc. as of December 31, 2018 and 2017, the related consolidated statements of operations and comprehensive loss, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2018, and the related notes and financial statement schedule III,(collectively, the “consolidated financial statements”), incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
Chicago, Illinois
November 4, 2019